Dr. Carlos Gil Ferreira, Ph.D.; President-elect of SBOC (Sociedade Brasileira de Oncologia Clínica); President of the Oncoclínicas Institute; CMO of the Oncoclínicas Group; member of the Board of the International Association for the Research and Treatment of Lung Cancer (IALSC)